News
NOTABLE RESEARCH HIGHLIGHTS
Our supported scientists have made remarkable advances in the fight against cancer. Here are some notable research highlights in 2025-2026 supported by your generous donations.
Advancing targeted therapies for gastrointestinal cancers
Our supported scientists are working to develop…
Cancer remains one of the leading causes of death worldwide, with nearly 10 million deaths each year. [1] With cancer continuing to affect the lives of so many people, it’s important to understand what steps we can take to prevent or reduce…
As cancer research continues to advance, increasing attention is being placed on both prevention and early intervention—two complementary approaches that can significantly reduce the global burden of cancer.
There are a few critical differences between intervening and preventing cancer.
What is Cancer Intervention?…
For people undergoing cancer treatment and for survivors, the right kind of physical activity can be a powerful way to support healing, improve overall well-being, and regain strength.
Why Exercise Matters for Cancer Patients and Survivors
Research shows that regular, safe exercise can:
…
The Asian Fund for Cancer Research Limited is proud to support Mr. Sunil Tuli, Group CEO of King Power Group (Hong Kong), on his remarkable Himalayan trek to raise critical funds for high-impact cancer research.
In February 2026, Mr. Tuli successfully completed the…
Many cancer patients seek complementary therapies to feel better, reduce side effects, and take an active role in their healing. When chosen carefully, these approaches can improve quality of life. However, some therapies may interfere with cancer treatments or cause harm.
What Are…
Our 2025 Give to Cure Cancer Year-End Appeal is now underway. Your generosity can make this our most impactful year yet. Thanks to supporters like you, AFCR-supported research achieved remarkable progress in 2025.
We are proud to share a few of this year’s…
Proper nutrition during and after cancer treatment plays a vital role in healing, strengthening the body, and improving quality of life. While nutrition alone cannot cure cancer alone, a balanced, healthy diet helps the body cope with treatment, rebuild strength, and support…
Breast cancer remains one of the most significant health threats today. For women, the lifetime risk is 1 in 8, and that risk is even higher for those with dense breast tissue. Though rare, men can also be diagnosed with breast cancer.
As…
Project Development & Fundraising Manager
Asian Fund for Cancer Research (AFCR) | Hong Kong | Full-Time
About AFCR
The Asian Fund for Cancer Research (AFCR) is a nonprofit organization advancing innovative cancer research and patient-centered solutions across Asia. AFCR builds collaborative platforms…
We are delighted to honor this year’s exceptional early-career Chinese cancer researchers for their significant achievements in advancing cancer research and drug development.
Since 2010, the Asian Fund for Cancer Research and the US Chinese Anti-Cancer Association have jointly presented the USCACA–AFCR…
Regular screenings improve early detection and treatment outcomes. Individuals with a family history, genetic predispositions (e.g., BRCA mutations), or other risk factors should consult their doctors for personalized screening guidance.
1. Breast Cancer
Age Group:
40-44: Optional annual mammogram. Women may choose to…
AFCR SUPPORTS various types of cancer and stages of research including basic, translational and clinical.
As we reach this meaningful twenty-year milestone, we honor the dedication of scientists, donors, and partners who have made these achievements possible.
The future holds even greater promise as…
The Asian Fund for Cancer Research (AFCR) is committed to supporting groundbreaking cancer research and promoting accurate, science-based health information. In light of recent public discussions and a fact-check article published by the Taiwan FactCheck Center, we wish to clarify AFCR’s position…
A Breakthrough Approach to “Undruggable” Targets
THE CHALLENGE: Undruggable Targets In Cancer
Many cancer-driving proteins remain out of reach for current treatments. These include transcription factors, RNA-binding proteins, and other intracellular regulators that lack suitable binding sites for traditional drugs. Biologic therapies,…